Bacil Pharma Limited (BOM:524516)
India · Delayed Price · Currency is INR 37.58
0.00 (0.00%)
At close: Jul 28, 2025
Sage Therapeutics Market Cap
Bacil Pharma has a market cap or net worth of 539.39 million as of August 1, 2025. Its market cap has increased by 490.44% in one year.
Market Cap
539.39M
Enterprise Value
512.45M
Revenue
n/a
Ranking
n/a
PE Ratio
54.46
Stock Price
$37.58
Market Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 539.39M, an increase of 2,374.12%. That is a compound annual growth rate of 19.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 539.39M | 68.53% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | 27.80M | 137.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 17.71T |
| HDFC Bank | 15.44T |
| Bharti Airtel | 11.30T |
| Tata Consultancy Services | 10.87T |
| ICICI Bank | 10.50T |
| State Bank of India | 7,329.73B |
| Infosys | 6,091.75B |
| Hindustan Unilever | 6,000.15B |